BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2498314)

  • 21. Dexamethasone inhibition of tissue-type plasminogen activator (tPA) activity: paradoxical induction of both tPA antigen and plasminogen activator inhibitor.
    Gelehrter TD; Sznycer-Laszuk R; Zeheb R; Cwikel BJ
    Mol Endocrinol; 1987 Jan; 1(1):97-101. PubMed ID: 3137452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of plasminogen activator (PA) and a PA inhibitor in human granulosa cells from preovulatory follicles.
    Jones PB; Muse KN; Wilson EA; Curry TE
    J Clin Endocrinol Metab; 1988 Oct; 67(4):857-60. PubMed ID: 3262121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage.
    Martel-Pelletier J; Zafarullah M; Kodama S; Pelletier JP
    J Rheumatol Suppl; 1991 Feb; 27():80-4. PubMed ID: 1851231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
    Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
    J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Modulation by plasminogen activator inhibitor type 1.
    Morton PA; Owensby DA; Sobel BE; Schwartz AL
    J Biol Chem; 1989 May; 264(13):7228-35. PubMed ID: 2540181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
    Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
    Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.
    Boxman IL; Quax PH; Löwik CW; Papapoulos SE; Verheijen J; Ponec M
    J Invest Dermatol; 1995 Mar; 104(3):374-8. PubMed ID: 7861005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
    Kooistra T; Bosma PJ; Toet K; Cohen LH; Griffioen M; van den Berg E; le Clercq L; van Hinsbergh VW
    Arterioscler Thromb; 1991; 11(4):1042-52. PubMed ID: 1648385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1.
    Keski-Oja J; Koli K
    J Invest Dermatol; 1992 Aug; 99(2):193-200. PubMed ID: 1629632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
    Michel JB; Quertermous T
    J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of proteolytic activity in human bone marrow stromal cells by basic fibroblast growth factor, interleukin-1, and transforming growth factor beta.
    Hannocks MJ; Oliver L; Gabrilove JL; Wilson EL
    Blood; 1992 Mar; 79(5):1178-84. PubMed ID: 1536945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of proteases type plasminogen activator and their inhibitor in cornea.
    Mirshahi M; Mirshahi S; Soria C; Soria J; Thomaidis A; Pouliquen Y; Faure JP
    Biochem Biophys Res Commun; 1989 May; 160(3):1021-5. PubMed ID: 2499321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of retinoic acid on human neuroblastoma: correlation between morphological differentiation and changes in plasminogen activator and inhibitor activity.
    Benjamin LA; McGarry RC; Hart DA
    Cancer Chemother Pharmacol; 1989; 25(1):25-31. PubMed ID: 2590998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.
    Bergonzelli GE; Kruithof EK
    J Cell Physiol; 1991 Aug; 148(2):306-13. PubMed ID: 1652590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.
    Wagner OF; Vetterlein M; Binder BR
    J Biol Chem; 1986 Nov; 261(31):14474-81. PubMed ID: 3490474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats.
    Andreasen PA; Kristensen P; Lund LR; Danø K
    Endocrinology; 1990 May; 126(5):2567-76. PubMed ID: 2109689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonal variation of expression of the genes coding for plasminogen activators, their inhibitors and the urokinase receptor in HT1080 sarcoma cells.
    Laug WE; Wang K; Mundi R; Rideout W; Kruithof EK; Bogenmann E
    Int J Cancer; 1992 Sep; 52(2):298-304. PubMed ID: 1325952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.